We therefore hypothesized that IL-1 might be causally linked to hyperandrogenemia in women with PCOS and aimed to investigate the effect of IL-1 pathway blockade with anakinra on androgen levels in women with PCOS. The gene discussed is IL1B; the disease is polycystic ovary syndrome.